Table 1.
Comparison of growth parameters and hormone tests results in the whole ISS group considering the presence of the H. pylori infection.
| H. pylori (+) | H. pylori (−) | p = | |
|---|---|---|---|
| n (F/M) | 15 (6/9) | 46 (19/27) | |
| CA (years) | 10.67 ± 3.44 | 9.85 ± 3.45 | 0.431 |
| HA (years) | 8.16 ± 2.94 | 7.39 ± 2.80 | 0.367 |
| HSDS | −2.45 ± 0.63 | −2.37 ± 0.93 | 0.764 |
| HV SDS | −1.55 ± 0.5 | −1.25 ± 0.37 | 0.311 |
| BMI SDS | −0.54 ± 0.65 | −0.29 ± 0.93 | 0.357 |
| ghrelin (pg/mL) | 1088.77 ± 271.48 | 1535.70 ± 838.54 | 0.048 * |
| leptin (ng/mL) | 4.79 | 8.58 ± 5.96 | 0.426 |
| IGF-1 SDS | −1.36 ± 1.36 | −0.92 ± 1.07 | 0.046 * |
| GH max after clonidine (ng/mL) | 17.16 ± 11.69 | 17.64 ± 10.22 | 0.498 |
| GH max after glucagon (ng/mL) | 8.44 ± 4.71 | 9.46 ± 5.93 | 0.395 |
H. pylori—Helicobacter pylori, CA—chronological age, HA—height age, HSDS—height standard deviation score, HV SDS—height velocity standard deviation score, BMI SDS—body mass index standard deviation score, GH max—maximal growth hormone concentration during stimulation test, IGF-1 SDS—insulin-like growth factor 1 standard deviation score, *—p < 0.05.